AVNT Quote, Financials, Valuation and Earnings

Aemetis has a net margin of -2.44% compared to Avient's net margin of -57.2%. Avient's return on equity of 4.27% beat Aemetis's return on equity of --.

Avient has a consensus price target of $43.17, signalling upside risk potential of 28.89%. On the other hand Aemetis has an analysts' consensus of $13.00 which suggests that it could grow by 416.69%. Given that Aemetis has higher upside potential than Avient, analysts believe Aemetis is more attractive than Avient.

Avient has a beta of 1.330, which suggesting that the stock is 32.958% more volatile than S&P 500. In comparison Aemetis has a beta of 1.573, suggesting its more volatile than the S&P 500 by 57.257%.

Avient has a quarterly dividend of $0.27 per share corresponding to a yield of 3.1%. Aemetis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avient pays 55.46% of its earnings as a dividend. Aemetis pays out -- of its earnings as a dividend. Avient's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avient quarterly revenues are $826.6M, which are larger than Aemetis quarterly revenues of $42.9M. Avient's net income of -$20.2M is higher than Aemetis's net income of -$24.5M. Notably, Avient's price-to-earnings ratio is 32.18x while Aemetis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avient is 0.98x versus 0.54x for Aemetis. Usually stocks with elevated PS ratios are considered overvalued.

Balchem has a net margin of -2.44% compared to Avient's net margin of 14.79%. Avient's return on equity of 4.27% beat Balchem's return on equity of 11.92%.

Avient has a consensus price target of $43.17, signalling upside risk potential of 28.89%. On the other hand Balchem has an analysts' consensus of $196.00 which suggests that it could grow by 20.1%. Given that Avient has higher upside potential than Balchem, analysts believe Avient is more attractive than Balchem.

Avient has a beta of 1.330, which suggesting that the stock is 32.958% more volatile than S&P 500. In comparison Balchem has a beta of 0.891, suggesting its less volatile than the S&P 500 by 10.888%.

Avient has a quarterly dividend of $0.27 per share corresponding to a yield of 3.1%. Balchem offers a yield of 0.53% to investors and pays a quarterly dividend of $0.87 per share. Avient pays 55.46% of its earnings as a dividend. Balchem pays out 19.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Avient quarterly revenues are $826.6M, which are larger than Balchem quarterly revenues of $250.5M. Avient's net income of -$20.2M is lower than Balchem's net income of $37.1M. Notably, Avient's price-to-earnings ratio is 32.18x while Balchem's PE ratio is 39.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avient is 0.98x versus 5.54x for Balchem. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of -2.44% compared to Avient's net margin of 7.44%. Avient's return on equity of 4.27% beat Innospec's return on equity of 2.21%.

Avient has a consensus price target of $43.17, signalling upside risk potential of 28.89%. On the other hand Innospec has an analysts' consensus of $115.00 which suggests that it could grow by 30.52%. Given that Innospec has higher upside potential than Avient, analysts believe Innospec is more attractive than Avient.

Avient has a beta of 1.330, which suggesting that the stock is 32.958% more volatile than S&P 500. In comparison Innospec has a beta of 1.047, suggesting its more volatile than the S&P 500 by 4.676%.

Avient has a quarterly dividend of $0.27 per share corresponding to a yield of 3.1%. Innospec offers a yield of 1.85% to investors and pays a quarterly dividend of $0.84 per share. Avient pays 55.46% of its earnings as a dividend. Innospec pays out 108.99% of its earnings as a dividend. Avient's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Innospec's is not.

Avient quarterly revenues are $826.6M, which are larger than Innospec quarterly revenues of $440.8M. Avient's net income of -$20.2M is lower than Innospec's net income of $32.8M. Notably, Avient's price-to-earnings ratio is 32.18x while Innospec's PE ratio is 83.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avient is 0.98x versus 1.24x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

WD-40 has a net margin of -2.44% compared to Avient's net margin of 20.43%. Avient's return on equity of 4.27% beat WD-40's return on equity of 37.54%.

Avient has a consensus price target of $43.17, signalling upside risk potential of 28.89%. On the other hand WD-40 has an analysts' consensus of $296.00 which suggests that it could grow by 27.86%. Given that Avient has higher upside potential than WD-40, analysts believe Avient is more attractive than WD-40.

Avient has a beta of 1.330, which suggesting that the stock is 32.958% more volatile than S&P 500. In comparison WD-40 has a beta of 0.144, suggesting its less volatile than the S&P 500 by 85.623%.

Avient has a quarterly dividend of $0.27 per share corresponding to a yield of 3.1%. WD-40 offers a yield of 1.57% to investors and pays a quarterly dividend of $0.94 per share. Avient pays 55.46% of its earnings as a dividend. WD-40 pays out 67.78% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Avient quarterly revenues are $826.6M, which are larger than WD-40 quarterly revenues of $146.1M. Avient's net income of -$20.2M is lower than WD-40's net income of $29.9M. Notably, Avient's price-to-earnings ratio is 32.18x while WD-40's PE ratio is 36.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avient is 0.98x versus 5.15x for WD-40. Usually stocks with elevated PS ratios are considered overvalued.